Aravind Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 13-12-2024
- Paid Up Capital ₹ 0.10 M
as on 13-12-2024
- Company Age 52 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -10.52%
(FY 2022)
- Profit -12.66%
(FY 2022)
- Ebitda 11.52%
(FY 2022)
- Net Worth 2.45%
(FY 2022)
- Total Assets 2.50%
(FY 2022)
About Aravind Laboratories
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Devanathan Hariprasad, Devanathan Balajhi, Krishnaswamy Srinivasan, and One other member serve as directors at the Company.
- CIN/LLPIN
U24299TN1972PTC006225
- Company No.
006225
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Sep 1972
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Aravind Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devanathan Hariprasad  | Director | 22-Apr-1999 | Current |
| Devanathan Balajhi | Director | 28-Sep-1972 | Current |
| Krishnaswamy Srinivasan | Director | 22-Apr-1999 | Current |
| Shanthi Rajagopal | Director | 28-Sep-1972 | Current |
Financial Performance of Aravind Laboratories.
Aravind Laboratories Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 10.52% decrease. The company also saw a substantial fall in profitability, with a 12.66% decrease in profit. The company's net worth moved up by a moderate rise of 2.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aravind Laboratories?
Unlock access to Aravind Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Healthtrack Info Solutions Private LimitedActive 23 years 5 monthsDevanathan Hariprasad is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aravind Laboratories?
Unlock and access historical data on people associated with Aravind Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aravind Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aravind Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
